EAM
ACHV icon

Eventide Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Eventide Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
+2,220,000
New +$10.6M 0.19% 132

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eventide Asset Management's ACHV Position: Q2 2026 in Review

Eventide Asset Management opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 2,220,000 shares worth $14.5M. The stake represents 0.19% of the portfolio and ranks #132 among its holdings.

85 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Eventide Asset Management held 2,220,000 shares of Achieve Life Sciences worth $14.5M as of Q2 2026.
  • Achieve Life Sciences was a new Eventide Asset Management position in Q2 2026.
  • Achieve Life Sciences made up 0.19% of Eventide Asset Management's portfolio in Q2 2026, its #132 holding.
  • 85 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.